HomePfizer stock forecast
The Pfizer stock forecast, using LSEG data, summarises the latest analyst ratings, price targets, and market sentiment for PFE.
The Pfizer stock forecast, using LSEG data, summarises the latest analyst ratings, price targets, and market sentiment for PFE.
Discover what analysts expect for Pfizer's share price outlook in 2025.
Forecast figures are sourced from LSEG and are for informational purposes only. This is not investment advice. Past performance is not a reliable indicator of future results.
Based on 30 analysts, Pfizer (PFE) holds a BUY consensus rating.
If a majority of analysts rate PFE as a Buy or Strong Buy, sentiment is broadly positive. If most analysts rate it Hold, sentiment is neutral, suggesting limited short-term momentum. If Sell or Strong Sell dominates, analysts currently see downside potential. These opinions may change over time and should not be taken as investment advice.
According to LSEG data, Pfizer share price forecasts indicate a 12-month price range between $23 and $37.54.
While short-term movements are normal, the average analyst target suggests longer-term expectations towards $28.85.
Past performance is not a reliable indicator of future results.
The current consensus rating is BUY, according to LSEG analyst data.
The average 12-month analyst price target for PFE is $28.85, according to aggregated third-party data.
The highest 12-month target for PFE (most optimistic) stands at $37.54.
The most cautious analyst estimate places PFE at $23 over the next year.
